Nitric oxide (NO) participates in the physiology and pathophysiology of every organ system. Of most importance, NO acts as an major mechanism of vasodilation, both under physiologic and toxic conditions. During the first 2.5 years of this project, we have identified several steps in the induction process of iNOS (microtubules, PTK, PKC, NF-kappaB), as well as mechanisms of NO-mediated control of soluble guanylate cyclase, the enzyme responsible for mediating most of the actions of NO. Recently, we also cloned 5.0 Kbases of the rat iNOS promoter and sequenced the 3.2Kbases apparently responsible for transcriptional control of the gene. In the proposed studies, we will investigate the molecular mechanisms involved in the promoter- dependent up-regulation of iNOS, and down-regulation of cNOS in vascular cells during immunological challenges. We hypothesize that NF-kB binding sites in the iNOS promoter are major elements in iNOS up- regulation in responding to immunomodulators; however, other factors (e.g., CRE) are also involved in iNOS expression; we further hypothesize that a similar NF-kappaB dependent signal transduction pathway is responsible for immunomodulator-induced endothelial cNOS down-regulation. Specifically, we will investigate 1) the essential element s of rat iNOS promoter in responding to cytokines and LPS stimulation, 2) the mechanism by which cAMP synergistically up-regulates the iNOS expression in rat ASMC in responding to cAMP and LPS, 3) the mechanism by which cytoskeleton disrupting agents decrease the iNOS expression and 4) differences between the rat and human iNOS promoter responsible for the weak iNOS up regulation in response to LPS and cytokines in human cells. Furthermore, 5) we will quantify LPS-, IL-1-, and TNF-induced oxidant stress and thiol depletion and determine the contribution of oxidants to reduced NO generation in LPS, IL-1 and TNF-treated EC, 6) we will investigate the kinetics and mechanisms of LPS, IL-1 and TNF-induced activation of protein kinases, NF- kappaB, cytoskeletal reorganization and determine the contribution of these mechanisms to cNOS down-regulation in cultured EC, 7) we will investigate the mechanisms of iNOS up-regulation in LPS- induced in rats, in vivo. Our findings should help clarify the role and mechanisms of iNOS activation and cNOS down-regulation under toxic conditions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL052958-04
Application #
2399106
Study Section
Special Emphasis Panel (ZRG4-ALTX-4 (01))
Project Start
1994-07-01
Project End
2000-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Medical College of Georgia (MCG)
Department
Biology
Type
Schools of Medicine
DUNS #
City
Augusta
State
GA
Country
United States
Zip Code
30912
Venema, Richard C; Venema, Virginia J; Ju, Hong et al. (2003) Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 285:H669-78
White, Richard E; Han, Guichun; Maunz, Melissa et al. (2002) Endothelium-independent effect of estrogen on Ca(2+)-activated K(+) channels in human coronary artery smooth muscle cells. Cardiovasc Res 53:650-61
Teng, Xingwu; Zhang, Hanfang; Snead, Connie et al. (2002) Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 282:C144-52
Beswick, R A; Zhang, H; Marable, D et al. (2001) Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37:781-6
Zhang, H; Snead, C; Catravas, J D (2001) Nitric oxide differentially regulates induction of type II nitric oxide synthase in rat vascular smooth muscle cells versus macrophages. Arterioscler Thromb Vasc Biol 21:529-35
Dimitropoulou, C; White, R E; Fuchs, L et al. (2001) Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels. Hypertension 37:301-7
Zhang, H; Teng, X; Snead, C et al. (2000) Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells. Br J Pharmacol 130:270-8
Teng, X; Zhang, H; Snead, C et al. (2000) A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells. Gen Pharmacol 34:16-Sep
Marczin, N; Go, C Y; Papapetropoulos, A et al. (1998) Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells. Br J Pharmacol 123:1000-8
Abou-Mohamed, G; Papapetropoulos, A; Catravas, J D et al. (1998) Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity. Eur J Pharmacol 341:265-72

Showing the most recent 10 out of 20 publications